Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Aim: To estimate the prevalence of Alzheimer’s disease (AD) and other dementias in the USA using a nationally representative sample. Methods: The Aging, Demographics, and Memory Study sample was composed of 856 individuals aged 71 years and older from the nationally representative Health and Retirement Study (HRS) who were evaluated for dementia using a comprehensive in-home assessment. An expert consensus panel used this information to assign a diagnosis of normal cognition, cognitive impairment but not demented, or dementia (and dementia subtype). Using sampling weights derived from the HRS, we estimated the national prevalence of dementia, AD and vascular dementia by age and gender. Results: The prevalence of dementia among individuals aged 71 and older was 13.9%, comprising about 3.4 million individuals in the USA in 2002. The corresponding values for AD were 9.7% and 2.4 million individuals. Dementia prevalence increased with age, from 5.0% of those aged 71–79 years to 37.4% of those aged 90 and older. Conclusions: Dementia prevalence estimates from this first nationally representative population-based study of dementia in the USA to include subjects from all regions of the country can provide essential information for effective planning for the impending healthcare needs of the large and increasing number of individuals at risk for dementia as our population ages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies suggest that racial and ethnic differences in dementia risk do not persist in rigorous analyses that account for health and socioeconomic factors.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [316]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies suggest that racial and ethnic differences in dementia risk do not persist in rigorous analyses that account for health and socioeconomic factors.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [343]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 3×
“S.[3] The four previous national estimates of AD prevalence estimates differed by greater than two-fold and ranged from 2.”
BackgroundMethodRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · cited 1×
“Currently accepted diagnostic criteria for subtypes of dementia were used.[19-21, 27] DSM criteria for dementia require memory impairment, however some subtypes of dementia do not present with prominent memory problems.”
MethodAlzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 2×
“5 million.[5,26] The lowest estimate came from a meta-analysis of 18 US and European studies; the highest from the East Boston and Chicago community studies.”
BackgroundBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787 · cited 1×
“[2-6], all employing extrapolations from a few U.”
Method
Research works printed but not linked: 6
- Evans DA, Scherr PA, Cook NR, Albert MS, Funkenstein HH, Smith LA, Hebert LE, Wetle TT, Branch LG, Chown M, Hennekens CH, Taylor JO. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q. 1990;68:267–289. [PubMed] [Google Scholar]
- United States General Accounting Office . Alzheimer's Disease: Estimates of Prevalence in the United States. Washington: United States General Accounting Office; 1998. [Google Scholar]
- Willis RJ. Theory confronts data: how the HRS is shaped by the economics of aging and how the economics of aging will be shaped by the HRS. Labour Econ. 1999;6:119–145. [Google Scholar]
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington: American Psychiatric Association; 1987. [Google Scholar]
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–1122. doi: 10.1001/archneur.60.8.1119. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- 10.1001%2fjama.278.16.1349 · doi:10.1001/jama.278.16.1349 · Paper page
Cited by
Items 101–200 of 1,002
Prevalence of dementia disorders in the oldest-old: an autopsy study
Jellinger, K. A., & Attems, J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0654-5 · Cited by 276
“In the USA, dementia prevalence increased with age from 5% in the eighth decade to 37.4% over age 95 years [ 95 ].”
BackgroundInfluential2008 Alzheimer's disease facts and figures
Alzheimer's Association (2008) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2008.02.005 · Cited by 247
“2, Alzheimer’s accounts for 70% f all cases of dementia in Americans age 71 and older [1].”
InfluentialSexual dimorphism in predisposition to Alzheimer's disease
Fisher, D. W., Bennett, D. A., & Dong, H. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.04.004 · Cited by 270
“Therefore, while the prevalence of AD is often reported to be higher for women compared to men due to the increase in risk by greater age, the relative increase in women living to more advanced ages makes it difficult to assess whether women also have an increased agedmatched risk of the disease (Brookmeyer et al., 19…”
The Value of Delaying Alzheimer’s Disease Onset
Zissimopoulos, J., Crimmins, E., & St.Clair, P. (2015) · Forum for Health Economics and Policy · doi:10.1515/fhep-2014-0013 · Cited by 267
Interventions to Improve Care for Patients with Limited Health Literacy.
Sudore, R. L., & Schillinger, D. (2009) · PubMed · Cited by 361
Di Marco, L. Y., Venneri, A., Farkas, E., Evans, P. C., Marzo, A., & Frangi, A. F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.014 · Cited by 262
“%) of dementia cases in the older population (Plassman et al., 2007;Whitehouse et al., 1997;Wilson et al., 2011).”
Clinical presentations and epidemiology of vascular dementia
Smith, E. E. (2017) · Clinical Science · doi:10.1042/cs20160607 · Cited by 249
Markers of T Cell Senescence in Humans
Xu, W., & Larbi, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081742 · Cited by 261
Amyloid β-Protein Monomer Folding: Free-Energy Surfaces Reveal Alloform-Specific Differences
Yang, M., & Teplow, D. B. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.039 · Cited by 247
Emerging Concepts in Vascular Dementia: A Review
Bir, S. C., Khan, M. W., Javalkar, V., Toledo, E. G., & Kelley, R. E. (2021) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2021.105864 · Cited by 223
Prince, M., Knapp, M., Guerchet, M., McCrone, P., Prina, M., Comas-Herrera, M., Wittenberg, A., Adelaja, R., Hu, B., King, B., et al. (2014) · Alzheimer's Society · doi:10.13140/2.1.3629.3446 · Cited by 250
Association of Race and Ethnicity With Incidence of Dementia Among Older Adults
Kornblith, E., Bahorik, A., Boscardin, W. J., Xia, F., Barnes, D. E., & Yaffe, K. (2022) · JAMA · doi:10.1001/jama.2022.3550 · Cited by 247
Preoperative Cognitive Dysfunction Is Related to Adverse Postoperative Outcomes in the Elderly
Robinson, T. N., Wu, D. S., Pointer, L. F., Dunn, C. L., & Moss, M. (2012) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2012.02.007 · Cited by 238
“Dementia is uncommon in individuals younger than 70 years old, occurs in 10% of individuals older than 70 years, and increases exponentially with age.(9,20,21) Common causes include neurodegenrative (eg, Alzheimer’s) and vascular disorders.”
Holland, D., Frei, O., Desikan, R., Fan, C.-C., Shadrin, A. A., Smeland, O. B., Sundar, V. S., Thompson, P., Andreassen, O. A., & Dale, A. M. (2020) · PLOS Genetics · doi:10.1371/journal.pgen.1008612 · Cited by 237
“…chip heritability, re-expressed as h 2 l on the liability scale for these case-control conditions assuming a prevalence of: MDD 7.1% [57], BIP 0.5% [58], SCZ 1% [59], CAD 3% [60], UC 0.1% [61], CD 0.1% [61], AD 14% (for people aged 71 and older in the USA [62, 63]), and ALS 5 × 10 − 5 [64].”
InfluentialCulley, D. J., Flaherty, D., Fahey, M. C., Rudolph, J. L., Javedan, H., Huang, C.-C., Wright, J., Bader, A. M., Hyman, B. T., Blacker, D., et al. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001859 · Cited by 239
Steenland, K., Goldstein, F. C., Levey, A., & Wharton, W. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150778 · Cited by 224
Mental work demands, retirement, and longitudinal trajectories of cognitive functioning.
Fisher, G. G., Stachowski, A., Infurna, F. J., Faul, J. D., Grosch, J., & Tetrick, L. E. (2014) · Journal of Occupational Health Psychology · doi:10.1037/a0035724 · Cited by 236
“Cognitive impairment is a highly prevalent, deleterious, and costly problem related to functional impairment and disability that affects more than one third of adults over age 70 in the United States (Hurd, Martorell, Delavande, Mullen, & Langa, 2013; Plassman et al., 2008; 2007).”
Self-citationBentwich, J., Dobronevsky, E., Aichenbaum, S., Shorer, R., Peretz, R., Khaigrekht, M., Marton, R. G., & Rabey, J. M. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0578-1 · Cited by 224
“Alzheimer’s disease (AD), the most common form of dementia in elderly people (van Duijn 1996; Fratiglioni et al. 2000; Plassman et al. 2007) is manifested by cognitive and behavioral derangements that markedly interfere with occupational and social functioning (Hyman et al.”
BackgroundSex and Gender Differences in Alzheimer's Disease: Recommendations for Future Research
Carter, C. L., Resnick, E. M., Mallampalli, M., & Kalbarczyk, A. (2012) · Journal of Women's Health · doi:10.1089/jwh.2012.3789 · Cited by 231
“Speculation continues that the gender effect on disease prevalence is because women live longer.(8,11) Because women survive to later ages than men, it is impossible to know if men who died would ever have developed AD at the same rate as that of women.”
Montreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementias
Davis, D. H., Creavin, S. T., Yip, J. L., Noel-Storr, A. H., Brayne, C., & Cullum, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010775.pub2 · Cited by 217
Aging and mental health in the decade ahead: What psychologists need to know
Karel, M. J., Gatz, M., & Smyer, M. A. (2012) · American Psychologist · doi:10.1037/a0025393 · Cited by 228
Islam, M. M., Iqbal, U., Walther, B., Atique, S., Dubey, N. K., Nguyen, P.-A., Poly, T. N., Masud, J. H. B., Li, Y.-C. (., & Shabbir, S.-A. (2016) · Neuroepidemiology · doi:10.1159/000454881 · Cited by 218
Langa, K. M., Ryan, L. H., McCammon, R. J., Jones, R. N., Manly, J. J., Levine, D. A., Sonnega, A., Farron, M., & Weir, D. R. (2020) · Neuroepidemiology · doi:10.1159/000503004 · Cited by 200
Self-citationJurcău, M. C., Andronie-Cioara, F. L., Jurcău, A., Marcu, F., Ţiț, D. M., Pașcalău, N., & Nistor-Cseppentö, D. C. (2022) · Antioxidants · doi:10.3390/antiox11112167 · Cited by 226
“7% in persons over 70 years of age [2,3].”
BackgroundMonetary Costs of Dementia in the United States
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1305541 · Cited by 211
Self-citationHigher Rates of Decline for Women and Apolipoprotein E ε4 Carriers
Holland, D., Desikan, R. S., Dale, A. M., & McEvoy, L. K. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3601 · Cited by 219
Cognitive decline and the neighborhood environment
Clarke, P. J., Weuve, J., Barnes, L., Evans, D. A., & Mendes de Leon, C. F. (2015) · Annals of Epidemiology · doi:10.1016/j.annepidem.2015.07.001 · Cited by 200
“Dementia is a common and disabling brain disorder among older adults that has consequences for independence, functional decline, institutionalization, and mortality (1, 2).”
BackgroundDi Marco, L. Y., Marzo, A., Muñoz-Ruiz, M., Ikram, M. A., Kivipelto, M., Ruefenacht, D., Venneri, A., Soininen, H., Wanke, I., Ventikos, Y. A., et al. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132225 · Cited by 215
“In a more recent study [9] on the prevalence of dementia in the United States, AD accounted for approximately 69.”
Obesity is linked with lower brain volume in 700 AD and MCI patients
Ho, A. J., Raji, C. A., Becker, J. T., Lopez, O. L., Kuller, L. H., Hua, X., Lee, S., Hibar, D., Dinov, I. D., Stein, J. L., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.006 · Cited by 204
Antoniou, M., Gunasekera, G. M., & Wong, P. C. M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.09.004 · Cited by 191
“Conservative estimates of the prevalence of Alzheimer’s disease are approximately 5% for those aged above 60 (Plassman et al., 2007), meaning that by 2050 there will be at least 100 million older adults diagnosed with Alzheimer’s disease worldwide (Ferri et al., 2005).”
BackgroundIpoacusia e declino cognitivo: revisione della letteratura
Fortunato, S., Forli, F., Guglielmi, V., De Corso, E., Paludetti, G., Berrettini, S., & FetonI, A. R. (2016) · Acta Otorhinolaryngologica Italica · doi:10.14639/0392-100x-993 · Cited by 190
Association Between Oral Health and Cognitive Status: A Systematic Review
Wu, B., Fillenbaum, G. G., Plassman, B. L., & Guo, L. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14036 · Cited by 200
“Furthermore, approximately 36% of individuals aged 70 and older are cognitively impaired,(4) and the prevalence of cognitive impairment and dementia increases with age.(5) Up to 5.”
BackgroundSelf-citationWeathers, E., O’Caoimh, R., Cornally, N., Fitzgerald, C., Kearns, T., Coffey, A., Daly, E., O’Sullivan, R., McGlade, C., & Molloy, D. W. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.06.016 · Cited by 212
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m14-0496 · Cited by 200
“The major dementia syndromes in older adults include Alzheimer disease, vascular dementia, frontotemporal dementia, dementia with Lewy bodies, Parkinson disease with dementia, and dementia of mixed cause (8).”
BackgroundCognitive function in the community setting: the neighbourhood as a source of ‘cognitive reserve’?
Clarke, P. J., Ailshire, J. A., House, J. S., Morenoff, J. D., King, K., Melendez, R., & Langa, K. M. (2012) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2010.128116 · Cited by 198
“Dementia is a common and disabling brain disorder among older adults that has consequences for independence, functional decline, institutionalization, and mortality (1–3).”
Self-citationPotter, G. G., Plassman, B. L., Burke, J. R., Kabeto, M. U., Langa, K. M., Llewellyn, D. J., Rogers, M. A. M., & Steffens, D. C. (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.04.1234 · Cited by 209
Self-citationThe Global Demography of Aging
(2016) · Handbook of the Economics of Population Aging · doi:10.1016/bs.hespa.2016.06.002 · Cited by 170
“70+ population using data from the Health and Retirement Survey (Hurd et al., 2013; Plassman et al., 2007).”
InfluentialDiogo, V. S., Ferreira, H. A., Prata, D., & Initiative, F. T. A. D. N. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01047-y · Cited by 184
“Alzheimer’s disease (AD) is one of the most prevalent health conditions in aging, affecting over 32 million people worldwide [1, 2].”
BackgroundCNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease?
Rezai-Zadeh, K., Gate, D., & Town, T. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9166-2 · Cited by 197
“West Nile encephalitis . multiple sclerosis . experimental autoimmune encephalomyelitis . human immunodeficiency virus . amyotrophic lateral sclerosis”
InfluentialLife Course Pathways to Racial Disparities in Cognitive Impairment among Older Americans
Zhang, Z., Hayward, M. D., & Yu, Y.-L. (2016) · Journal of Health and Social Behavior · doi:10.1177/0022146516645925 · Cited by 192
Cognitive and Behavioral Neurology
Finger, E., & Daffner, K. R. (2012) · Neurology · doi:10.1007/978-0-387-88555-1_8 · Cited by 200
Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders
Pinares-Garcia, P., Stratikopoulos, M., Zagato, A., Loke, H., & Lee, J. (2018) · Brain Sciences · doi:10.3390/brainsci8080154 · Cited by 200
“This female-bias is not seen in any other types of dementias [92], although some have reasoned that it is a result of women living longer than men [93].”
BackgroundImpact of aging brain circuits on cognition
Samson, R. D., & Barnes, C. A. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12183 · Cited by 183
“Plassman et al. (2007) examined the prevalence of dementia in a representative sample taken from all regions of the United States in people over 70 years of age.”
BackgroundConvergent genetic and expression data implicate immunity in Alzheimer's disease
International Genomics of Alzheimer's Disease Consortium (IGAP), Jones, L., Lambert, J., Wang, L., Choi, S., Harold, D., Vedernikov, A., Escott‐Price, V., Stone, T., Richards, A., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.05.1757 · Cited by 199
“Alzheimer’s disease (AD) affects more than five million Americans: one in eight at the age of .65 years and represents .60% of the six million dementia cases in Europe [1–3].”
Yorkston, K. M., Bourgeois, M. S., & Baylor, C. R. (2010) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2009.12.011 · Cited by 179
Wayfinding for People with Dementia: A Review of the Role of Architectural Design
Marquardt, G. (2011) · HERD: Health Environments Research & Design Journal · doi:10.1177/193758671100400207 · Cited by 173
Adherence to a Mediterranean diet and risk of incident cognitive impairment
Tsivgoulis, G., Judd, S., Letter, A. J., Alexandrov, A. V., Howard, G., Nahab, F., Unverzagt, F. W., Moy, C., Howard, V. J., Kissela, B., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182904f69 · Cited by 183
“70 years.(1) Currently there are no preventive or curative pharmaceutical measures.”
BackgroundThe prevalence and incidence of dementia: a systematic review and meta-analysis
Fiest, K. M., Jetté, N., Roberts, J. I., Maxwell, C. J., Smith, E. E., Black, S. E., Blaikie, L., Cohen, A., Day, L., Holroyd-Leduc, J., et al. (2016) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2016.18 · Cited by 188
Sex hormones aging and Alzheimer s disease
Pike, C. J. (2012) · Frontiers in Bioscience · doi:10.2741/e434 · Cited by 156
“In fact, like several diseases, AD is characterized by an increased prevalence in women (32-38).”
BackgroundNelson, P. T., Brayne, C., Flanagan, M. E., Abner, E. L., Agrawal, S., Attems, J., Castellani, R. J., Corrada, M. M., Cykowski, M. D., Di, J., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02444-1 · Cited by 174
Cognitive impairment in the U.S.: Lifetime risk, age at onset, and years impaired
Hale, J. M., Schneider, D. C., Mehta, N. K., & Myrskylä, M. (2020) · SSM - Population Health · doi:10.1016/j.ssmph.2020.100577 · Cited by 204
Li, F.-J., Shen, L., & Ji, H.-F. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120349 · Cited by 173
“The prevalence of AD is expected to rise steadily worldwide with aging demographics of human society [1–3], and unfortunately, there is no effective drug to treat this disorder.”
BackgroundSerum 25-Hydroxyvitamin D Concentration and Cognitive Impairment
Llewellyn, D. J., Langa, K. M., & Lang, I. A. (2009) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988708327888 · Cited by 181
Self-citationDementia of the Alzheimer Type
Jalbert, J. J., Daiello, L. A., & Lapane, K. L. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn008 · Cited by 174
“(302) Nationally representative sample of the US population (N 5 856) aged 71 years or older 71–79 years of age: 5.”
BackgroundWebb, L. M., & Chen, C. Y. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5647 · Cited by 216
“9% of all Americans age 71 or older have some form of major neurocognitive disorder.(41) The COVID‐19 pandemic has exacerbated stresses on this already vulnerable COMMENTARY - 3”
BackgroundDeFina, L. F., Willis, B. L., Radford, N. B., Gao, A., Leonard, D., Haskell, W. L., Weiner, M. F., & Berry, J. D. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-3-201302050-00005 · Cited by 169
“The cross-sectional prevalence of dementia is somewhat lower than expected (43), due in part to the underestimation of disease by Medicare data and the lower burden of risk factors in this cohort, but it is associated appropriately with increasing age.”
BackgroundSabbagh, M., Sadowsky, C., Tousi, B., Agronin, M. E., Alva, G., Armon, C., Bernick, C., Keegan, A. P., Karantzoulis, S., Baror, E., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.08.197 · Cited by 167
The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE
Gottesman, R. F., Schneider, A. L. C., Zhou, Y., Chen, X., Green, E., Gupta, N., Knopman, D. S., Mintz, A., Rahmim, A., Sharrett, A. R., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002914 · Cited by 172
Feil, D. G., Zhu, C. W., & Sultzer, D. L. (2012) · Journal of Behavioral Medicine · doi:10.1007/s10865-011-9344-6 · Cited by 160
Trends in Antipsychotic Use in Dementia 1999-2007
Kales, H. C., Zivin, K., Kim, H. M., Valenstein, M., Chiang, C., Ignacio, R. V., Ganoczy, D., Cunningham, F., Schneider, L. S., & Blow, F. C. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.200 · Cited by 170
Montreal Cognitive Assessment for the detection of dementia
Davis, D. H., Creavin, S. T., Yip, J. L., Noel-Storr, A. H., Brayne, C., & Cullum, S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010775.pub3 · Cited by 132
Souillard-Mandar, W., Davis, R., Rudin, C., Au, R., Libon, D. J., Swenson, R., Price, C. C., Lamar, M., & Penney, D. L. (2016) · Machine Learning · doi:10.1007/s10994-015-5529-5 · Cited by 163
Past, Present, and Future of Healthy Life Expectancy: Figure 1.
Beltrán-Sánchez, H., Soneji, S., & Crimmins, E. M. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025957 · Cited by 151
“Moreover, it is estimated that the prevalence of dementia in the early 2000s at ages 71þ was 14% and 10% for Alzheimer’s disease specifically (Plassman et al. 2007), although some substantial portion of the increase is likely attributable to better diagnosis.”
Aging in two languages: Implications for public health
Bialystok, E., Abutalebi, J., Bak, T. H., Burke, D. M., & Kroll, J. F. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.03.003 · Cited by 157
Speed of processing training results in lower risk of dementia
Edwards, J. D., Xu, H., Clark, D. O., Guey, L. T., Ross, L. A., & Unverzagt, F. W. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.09.002 · Cited by 160
“Dementia affects 14% of persons aged 71 years and older and 30% of those over the age 90 [1].”
BackgroundResultBerberine: A Potential Multipotent Natural Product to Combat Alzheimer’s Disease
Ji, H.-F., & Shen, L. (2011) · Molecules · doi:10.3390/molecules16086732 · Cited by 166
“As the most common form of dementia, Alzheimer’s disease (AD) has been one of the most threatening diseases in the elderly with the accelerated aging of human society [1-4].”
BackgroundPrognostic factors in paediatric anaplastic large cell lymphoma role of ALK
Woessmann, W. (2015) · Frontiers in Bioscience · doi:10.2741/434 · Cited by 150
Radiosyntheses using Fluorine-18: The Art and Science of Late Stage Fluorination
Cole, E. L., Stewart, M. N., Littich, R., Hoareau, R., & Scott, P. J. H. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140202205035 · Cited by 192
Fasae, K. D., Abolaji, A. O., Faloye, T. R., Odunsi, A. Y., Oyetayo, B. O., Enya, J. I., Rotimi, J. A., Akinyemi, R. O., Whitworth, A. J., & Aschner, M. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126779 · Cited by 154
Peterson, K., Hahn, H., Lee, A. J., Madison, C. A., & Atri, A. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0338-7 · Cited by 143
“4 million people living with Alzheimer’s Disease [2], and more individuals are affected when other forms of dementia or cognitive impairment are included [3, 4].”
Bertens, L. C. M., Broekhuizen, B. D. L., Naaktgeboren, C. A., Rutten, F. H., Hoes, A. W., van Mourik, Y., Moons, K. G. M., & Reitsma, J. B. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001531 · Cited by 158
“Study characteristics are summarized in Tables 1–5 by medical domain: Table 1 for psychiatric disorders [12–41], Table 2 for cardiovascular disorders [42–58], Table 3 for respiratory disorders [59–68], Table 4 for studies with multiple target diseases [69–75], and Table 5 for diseases from other medical domains [76–92…”
Assessing Potential Glycemic Overtreatment in Persons at Hypoglycemic Risk
Tseng, C.-L., Soroka, O., Maney, M., Aron, D. C., & Pogach, L. M. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12963 · Cited by 161
The Epidemiology of Vascular Dementia
Ozbabalk, D., Arslanta, D., & Tuncer, N. (2012) · Geriatrics · doi:10.5772/25840 · Cited by 158
Current treatments for sleep disturbances in individuals with dementia
Deschenes, C. L., & McCurry, S. M. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0004-2 · Cited by 157
“As a result of the aging baby boomer population, by the year 2050, it is projected that 60% of those over the age of 85 years— 11 to 16 million individuals—will have AD [1, 6 ].”
BackgroundMcKenzie, A. T., Moyon, S., Wang, M., Katsyv, I., Song, W.-M., Zhou, X., Dammer, E. B., Duong, D. M., Aaker, J., Zhao, Y., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0219-3 · Cited by 154
“Although the number one risk factor for AD is advanced age, the reason for this remains unknown [2, 3].”
BackgroundAlonso, A., Mosley, T. H., Gottesman, R. F., Catellier, D., Sharrett, A. R., & Coresh, J. (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.176818 · Cited by 147
“Alzheimer disease is the diagnosis given in approximately 70% of total dementia cases, while 20% are labelled as vascular dementia, the rest being ascribed to miscellaneous aetiologies.(1) Nonetheless, pathological evidence has shown considerable overlap between Alzheimer disease and vascular dementia,(5) suggesting t…”
BackgroundBulut, E. A., Soysal, P., & Işık, A. T. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s180281 · Cited by 172
Zissimopoulos, J. M., Tysinger, B. C., St.Clair, P. A., & Crimmins, E. M. (2018) · The Journals of Gerontology: Series B · doi:10.1093/geronb/gbx147 · Cited by 142
Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on
Maki, P. M., & Henderson, V. W. (2012) · Climacteric · doi:10.3109/13697137.2012.660613 · Cited by 144
Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?
Whyte, L. S., Lau, A. A., Hemsley, K. M., Hopwood, J. J., & Sargeant, T. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13935 · Cited by 150
Periodontal disease, tooth loss and dementia: Is there a link? A systematic review
Tonsekar, P. P., Jiang, S. S., & Yue, G. (2017) · Gerodontology · doi:10.1111/ger.12261 · Cited by 136
Fredriksen-Goldsen, K. I., Jen, S., Bryan, A. E. B., & Goldsen, J. (2018) · Journal of Applied Gerontology · doi:10.1177/0733464816672047 · Cited by 148
“, 2008) and 14% were living with some form of dementia (Plassman et al., 2007).”
InfluentialVitamin D and neurocognitive function
Holick, M., & Schlogl, M. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s51785 · Cited by 143
“According to The Aging, Demographics, and Memory Study (ADAMS), the prevalence of VaD in the United States among those aged 71 years and older has been estimated to be approximately 594,000.(125) The development of clinical AD and VaD is very complex,(126,127) since several pathophysiological pathways leading to vascu…”
Frailty, nutrition-related parameters, and mortality across the adult age spectrum
Jayanama, K., Theou, O., Blodgett, J. M., Cahill, L. E., & Rockwood, K. J. (2018) · BMC Medicine · doi:10.1186/s12916-018-1176-6 · Cited by 157
Magnuson, A. M., Sattar, S., Nightingale, G., Saracino, R. M., Skonecki, E., & Trevino, K. M. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_237641 · Cited by 166
Duberstein, P. R., Chapman, B. P., Tindle, H. A., Sink, K. M., Bamonti, P., Robbins, J., Jerant, A. F., & Franks, P. (2011) · Psychology and Aging · doi:10.1037/a0021377 · Cited by 146
Reid, G. A., & Darvesh, S. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.039 · Cited by 148
Landau, R., Auslander, G. K., Werner, S., Shoval, N., & Heinik, J. (2010) · Qualitative Health Research · doi:10.1177/1049732309359171 · Cited by 138
“According to Plassman et al. (2007), the prevalence of dementia in the United States in 2002 among individuals aged 71 and older was 13.9%, comprising about 3.4 million individuals.”
BackgroundInfluentialAlzheimer's Disease: A Clinical and Basic Science Review
Korolev, I. O. (2014) · Cited by 196
Estrogen receptors and the aging brain
Maioli, S., Leander, K., Nilsson, P., & Nalvarte, I. (2021) · Essays in Biochemistry · doi:10.1042/ebc20200162 · Cited by 153
Savva, G. M., & Arthur, A. (2015) · Age and Ageing · doi:10.1093/ageing/afv020 · Cited by 136
“HRS is a nationally representative longitudinal study of ageing in the United States which began in 1992 [14].”
BackgroundInfluentialAn epigenetic hypothesis of aging-related cognitive dysfunction
Penner (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00009 · Cited by 142
“While this disease and many others are certainly devastating, it is also true that most people will not suffer from a dementing condition as they age; the prevalence of dementia among individuals aged 71 and older is 13.9% (Plassman et al., 2007).”
InfluentialYochim, B. P., Mueller, A. E., Kane, K. D., & Kahook, M. Y. (2012) · Journal of Glaucoma · doi:10.1097/ijg.0b013e3182071b7e · Cited by 144
Functional Disability, Cognitive Impairment, and Depression After Hospitalization for Pneumonia
Davydow, D. S., Hough, C. L., Levine, D. A., Langa, K. M., & Iwashyna, T. J. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.12.006 · Cited by 149
Self-citationZeki Al Hazzouri, A., Haan, M. N., Kalbfleisch, J. D., Galea, S., Lisabeth, L. D., & Aiello, A. E. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq483 · Cited by 136
Fuzzy-trace theory and lifespan cognitive development
Brainerd, C. J., & Reyna, V. F. (2015) · Developmental Review · doi:10.1016/j.dr.2015.07.006 · Cited by 112
Epidemiological of and risk factors for Alzheimer's disease: A review
Povova, J., Ambroz, P., Bar, M., Pavukova, V., Sery, O., Tomaskova, H., & Janout, V. (2012) · Biomedical Papers · doi:10.5507/bp.2012.055 · Cited by 136
Lin, P., Fillit, H. M., Cohen, J. T., & Neumann, P. J. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.002 · Cited by 142
“The ADRD prevalence rates in our sample were comparable to other estimates [12–14].”
ResultRoss, M., Grossmann, I., & Schryer, E. (2014) · Perspectives on Psychological Science · doi:10.1177/1745691614535935 · Cited by 132
“The occurrence of dementia is estimated to increase from about 1% at 60–64 years of age to about 37% at more than 90 years of age, roughly doubling every 5 years after 65 years of age (Canadian Study of Health and Aging Working Group, 1994; Plassman et al., 2007).”
BackgroundAcupuncture for patients with mild to moderate Alzheimer’s disease: a randomized controlled trial
Jia, Y., Zhang, X., Yu, J., Han, J., Yu, T., Shi, J., Zhao, L., & Nie, K. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-2064-x · Cited by 142
“More and more people pay attention to AD because the decline in memory and other cognitive functions leads to a loss of independence which has a wideranging impact on individuals, families and healthcare systems [6].”
Background
Metadata
- Authors
- Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., Steffens, D. C., Willis, R. J., & Wallace, R. B.
- Affiliations
- Duke University (US)
- University of Michigan (US)
- Duke Medical Center (US)
- RAND Corporation (US)
- University of Iowa (US)
- ORCID
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 29
- Issue
- 1-2
- Pages
- 125-132
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- PMC
- PMC2705925
- OpenAlex
- W2133488570
- Cited by
- 1,932
- References
- 44
- Citations by year
- 2026: 36 · 2025: 77 · 2024: 68 · 2023: 76 · 2022: 109 · 2021: 144 · 2020: 152 · 2019: 108 · 2018: 107 · 2017: 111 · 2016: 122 · 2015: 123 · 2014: 153 · 2013: 126 · 2012: 121
- FWCI
- 38.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuroepidemiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (K08AG019180, U01 AG 09740, U01AG009740)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- dementia prevalence, Alzheimer's disease, vascular dementia, older adults, cognitive impairment, age differences, sex differences, population aging, health planning
- MeSH terms
- Aged, Aged, 80 and over, Dementia, Female, Health Surveys, Humans, Male, United States, Cohort Studies, Geriatric Assessment, Prevalence, Logistic Models, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.